Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.

doi:10.1159/000214857

Article

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.

Acta haematologica - 1 Jan 2009

Michiels Jan Jacques, van Vliet Huub H D M, Berneman Zwi, Schroyens Wilfried, Gadisseur Alain

Abstract excerpt

Guidelines and recommendations for the acute and prophylactic treatment of bleeding in von Willebrand disease (VWD) patients with von Willebrand factor (VWF)/factor VIII (FVIII) concentrates should be based on the analysis of the content of VWF/FVIII concentrates and on pharmacokinetic studies in patients with different severity of VWD (type 1, type 2 or type 3). The VW/FVIII concentrates should be assessed using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.

Abstract excerpt

Topics

Related research